CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 10,099 shares at $287.46 ($2,903,059)
- 4 Open-market sale Director sold 274,092 shares at $287.46 ($78,790,486)
- 4 Open-market sale Chief Executive Officer sold 73,526 shares at $287.46 ($21,135,784)
- 4 Open-market sale Chief Medical Officer, EVP R&D sold 73,526 shares at $287.46 ($21,135,784)
- 4 Open-market sale Director sold 280,000 shares at $287.46 ($80,488,800)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 2,000 shares at an average $16.12 ($32,236)
- 4 Open-market buy Director bought 3,550 shares at an average $16.12 ($57,209)
- 4 Open-market buy Director bought 3,550 shares at an average $15.88 ($56,358)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 13 of 29 · 564 filings